This study focuses on patients with Coronary Artery Disease who experience stable chest pain. The research examines how statin therapy affects the characteristics of coronary artery plaques, which are deposits that can build up in blood vessels of the heart. The study uses Coronary Computed Tomography Angiography, a specialized imaging technique that creates detailed pictures of heart blood vessels.
The treatment involves comparing two medications: Xeter (which contains rosuvastatin, a type of statin medication that helps lower cholesterol) and placebo. The study aims to measure changes in the volume and composition of plaques in heart arteries after three months of treatment.
During the study, participants will undergo heart imaging at the beginning of the study and after three months of taking either Xeter or placebo. The medication is taken as a film-coated tablet by mouth. The maximum daily dose of Xeter is 40 milligrams, and treatment continues for up to 12 months. The study will track various aspects of heart health and monitor how the plaques in the arteries may change over time.



Hungary